Cardiology. myocardial pelo

pelo myocardial bua ka diso bao e seng a hlabang tsa mesifa pelo. Sena "diffuse" thulaganyou e isang phytoteratology tshebetsong ya intracellular dibopeho myofibrils. Tabeng ena, ho na le fokolisang tsa contractility myocardial. hloleha ena e khethehileng, e haufi-ufi amanang le ditlolo skeletal kapa physicochemical ea metabolism lona.

Myocardiodystrophy. le matšoao

Jwalo ka e bontša liketso, lipontšo tsa hlōloa hangata masked ke liponahatso tsa lefu lena le se ipatileng. pelo myocardial e tsamaea le mokhathala, dyspnoea le mojaro nyenyane, muting ka tlhorong ea pelo 1st molumo ka tsela e itekanetseng tachycardia (ho tloha nako le nako). Hangata e tsamaea le khaello ea mali, systolic khabole tsa mothapo methapo le keletso. Thyrotoxicosis e tsamaea le bohloko sefubeng, e ile ea eketseha pulse length le ho hatelloa ke systolic mali, tachycardia (bitsoa), atrial fibrillation. Ho sa tsotellehe hore lisosa tsa pelo myocardial akarelletsa ntshetsopele ya ho hloleha pelo le tlōlo ea morethetho hae.

bakang ka 'na ba mafu alimentary dystrophy, khaello vithamine, chefo le palokatiso (chefo le barbiturates kapa carbon monoxide kapa botahoa joala).

Climacteric myocardial pelo develops ka basali nakong menopause. Bakeng sa lefu lena le tšoauoa ka phehella, opeloa kapa hlabang bohloko ka tlhorong cardiac, se amanang le mojaro oa ka tlhaho 'mele. Matšoao a ka 'na mpefala nakong premenstrual le tsamaea le e phallang ea sefahleho, mahlaseli a chesang le ho fufuleloa. Ka tloaelo ho, bohloko namela lehlakoreng le letšehali la sefubeng, 'me ba tsoarellang haholo. Tabeng ena, nitroglycerin ho a sa tlise e le hantle. Maemong a mang, ho fumanoa ka ho tlōla morethetho cardiac. E le kalafo e atlehang laetsoeng ho kopanela liphate li-hormone, sedatives le beta-blockers hammoho.

Tshebediso ya ho noa joala ka nako lekaneng telele baka tšenyo chefo bang mesebetsi intracellular ka myofibrils. Lefu lena le e tsamaea le palpitations, khohlela, boikutlo ba ho hloka moea. E le matšoao a hlokomela e le fibrillation atrial, otla pele ho nako kapa tachycardia. Pelo hangata eketsa ka boholo, 'me lentsoe le lona ke kgutsisitswe. Lefu lena le e tsamaea le lipontšo tsa matšoao a ho lemalla joala bo sa foleng. Lefu lena le ke ka toka lieha. Maemong a mangata, ho cessation ea tšebeliso ea lino tse tahang e isa ho nyamela ha matšoao.

Haeba u hlokomela ka mekhahlelo ea pele ea palpitation, bokhutšoanyane phefumoloho, mokhathala, bohloko ba ka pelo e fumanoa myocardial tireotoksikoznaya. Phekolo tabeng ena o ikemiseditse ho felisa hyperthyroidism. Hlokomela hore ho na le thyrotoxicosis bitsoa haholo thibela cupping etsahalang atrial fibrillation. Tabeng ena, ho atleha le ho bomaleba sharply fokotsa kapa u hle hyperthyroidism. Bakeng sa merero tsena ka liponahatso mathoasong a ho laela beta-blockers kapa reserpine. Ha pontšo ea pelo ea ho hloleha balletsweng diuretics le glycosides cardiac.

Ka hypothyroidism tshenyo ho mesifa pelo e tlatsetsang ho fumanoe mathomo. Tabeng ena, ho na le ke slowdown ka atrioventricular le atrioventricular conduction. Maemong a sa tloaelehang, le arrhythmia e lemoha.

Ka kakaretso, kalafo o ikemiseditse ho dithulaganyo tshilong ya dijo. Sephetho entsoeng ka tlōlo ea morethetho le conduction, hammoho le ha pelo. Bakuli ba beuweng Pananginum, kokarboksilazu, Riboxinum, ATP, orotate potassium, inositol. Ho phaella moo, ho molemo ho baeti ba fihlelang ho ea anabolic hormone (methandrostenolone, Retabolilum), B-divithamini, beta-adrenablokatorov. Ha lino tse tahang e contraindicated ka diso tsa ho noa joala. Prescribers, ho ntlafatsa myocardial metabolism (anabolic steroid, cocarboxylase, Pananginum, Riboxinum, ATP). Beta-blockers li lumelloa ka tekanyetso e nyenyane.